Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Cefewel T Cefepime & Tazobactam Injection 281.25 mg:
Cefewel T Cefepime & Tazobactam Injection 281.25 mg is a broad-spectrum antibiotic combination designed to combat severe bacterial infections. It provides enhanced efficacy through the synergistic action of Cefepime and Tazobactam, targeting resistant bacteria.
Uses of Cefewel T Cefepime & Tazobactam Injection 281.25 mg:
Cefewel T is used for the treatment of a variety of serious infections, including pneumonia, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, and sepsis. It is effective against both Gram-positive and Gram-negative pathogens, including resistant strains.
Benefits of Cefewel T Cefepime & Tazobactam Injection 281.25 mg:
Broad-spectrum antibacterial action
Effective against beta-lactamase-producing bacteria
Rapid onset of action with intravenous administration
Ideal for severe and resistant bacterial infections in critical care
Mechanism of Action of Cefewel T Cefepime & Tazobactam Injection 281.25 mg:
Cefepime inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis. Tazobactam protects Cefepime from beta-lactamase enzymes, expanding its spectrum of activity and allowing it to effectively target resistant bacteria. This combination results in potent bactericidal effects against a wide range of pathogens.